Hematopoietic Stem Cell Transplantation Market Growth Analysis 2024 – Forecast Market Size And Key Factors Driving Growth

Overview and Scope
Hematopoietic stem cell transplantation (HSCT) refers to the process of a medical procedure that is used to treat various blood and bone marrow disorders, such as certain genetic disorders and autoimmune diseases. The procedure involves replacing a patient’s damaged or diseased bone marrow with healthy stem cells from a donor, which then grow and produce new blood cells in the patient’s body. These stem cells can be obtained from bone marrow, peripheral blood, or umbilical cord blood.

Sizing and Forecast
The hematopoietic stem cell transplantation market size has grown strongly in recent years. It will grow from $4.24 billion in 2023 to $4.65 billion in 2024 at a compound annual growth rate (CAGR) of 9.6%.  The  growth in the historic period can be attributed to early transplantation techniques, limited indications and donor sources, advancements in conditioning regimens, emergence of allogeneic transplants, regulatory milestones.

The hematopoietic stem cell transplantation market size is expected to see rapid growth in the next few years. It will grow to $6.82 billion in 2028 at a compound annual growth rate (CAGR) of 10.1%.  The growth in the forecast period can be attributed to expanded treatment indications, donor source diversification, personalized medicine and genomics, regulatory changes and guidelines, market expansion and accessibility. Major trends in the forecast period include advancements in transplant techniques, expansion of indications, emerging cellular therapies, donor diversification, precision medicine approach.

To access more details regarding this report, visit the link:
https://www.thebusinessresearchcompany.com/report/hematopoietic-stem-cell-transplantation-global-market-report

Segmentation & Regional Insights
The hematopoietic stem cell transplantation market covered in this report is segmented –

1) By Type: Allogeneic, Autologous
2) By Indication: Leukemia, Lymphatic Disorder, Myeloma, Other Non-Malignant Disorders
3) By Application: Bone Marrow Transplant, Peripheral Blood Stem Cell Transplant, Cord Blood Transplant
4) By End User: Hospital Pharmacy, Retail Pharmacy, Specialty Clinics

North America was the largest region in the hematopoietic stem cell transplantation market in 2023. Asia-Pacific is expected to be the fastest-growing region in the global hematopoietic stem cell transplantation market during the forecast period. The regions covered in the hematopoietic stem cell transplantation market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Intrigued to explore the contents? Secure your hands-on sample copy of the report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=10445&type=smp

Major Driver Impacting Market Growth
The increased frequency of blood cancer is expected to propel the growth of the hematopoietic stem cell transplantation market. A group of malignancies that impact the development and operation of blood cells are referred to as blood cancers. Leukemia, lymphoma, and myeloma are the three main types of blood cancer. By replacing stem cells and bone marrow cells that have been killed by the malignancy, hematopoietic stem cell transplantation is generally used to treat blood cancer. These new stem cells can then move to the bone marrow and start creating new blood cells. So, these factors boost the hematopoietic stem cell transplantation market. For instance, in August 2022, according to the report shared by Blood Cancer UK, a UK-based non-profit organization, there are 41,000 blood cancer cases identified each year, making blood cancer the sixth most prevalent malignancy in the UK. Blood cancer, which affects one in 16 men and one in 22 women at some time in their lives, will afflict around 250,000 people in the UK in 2022. Additionally, more than 500 children under the age of 15 are affected by blood cancer each year. 400 of them have pediatric leukemia, and 100 of them have lymphoma. Therefore, the increased frequency of blood cancer drives the hematopoietic stem cell transplantation market.

Key Industry Players
Major companies operating in the hematopoietic stem cell transplantation market report are Pluristem Therapeutics Inc., Lonza Group AG, Escape Therapeutics Inc., Regen Biopharma Inc., Bluebird Bio Inc., CellGenix GmbH, CBR Systems  Inc., Merck KGaA, Cord Blood Corporation, Kiadis Pharma NV, Marker Therapeutics Inc., Taiga Biotechnologies Inc., Takeda Pharmaceutical Company Limited, Talaris Therapeutics Inc., ViaCord LLC, ScienCell Research Laboratories  Inc., BiolineRx, Stemcell Technologies Inc., ThermoGenesis Holdings Inc., MEDIPOST Co. Ltd., Anterogen. Co. Ltd., Pharmicell Inc., NuVasive  Inc., RTI Surgical Ltd., JCR Pharmaceuticals Co. Ltd., Holostem Terapie Avanzate Srl, Regrow Biosciences Pvt Ltd., Stempeutics Research Pvt Ltd., 3D Biomatrix, Worthington Biochemical

The hematopoietic stem cell transplantation  market report table of contents includes:

1. Executive Summary
2. Hematopoietic Stem Cell TransplantationMarket Characteristics
3. Hematopoietic Stem Cell TransplantationMarket Trends And Strategies
4. Hematopoietic Stem Cell TransplantationMarket – Macro Economic Scenario
5. Global Hematopoietic Stem Cell TransplantationMarket Size and Growth
.
.
.
31. Global Hematopoietic Stem Cell TransplantationMarket Competitive Benchmarking
32. Global Hematopoietic Stem Cell TransplantationMarket Competitive Dashboard
33. Key Mergers And Acquisitions In The Hematopoietic Stem Cell TransplantationMarket
34. Hematopoietic Stem Cell TransplantationMarket Future Outlook and Potential Analysis
35. Appendix

Explore the trending research reports from TBRC:
https://www.thebusinessresearchcompany.com/report/blood-glucose-meters-global-market-report
https://www.thebusinessresearchcompany.com/report/blood-transfusion-diagnostics-global-market-report
https://www.thebusinessresearchcompany.com/report/patient-blood-management-global-market-report

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model